J.P. Morgan said it believes Structure has some advantages over other companies trying to enter the oral GLP-1 market, ...

GLP-1 agonist drugs like Novo Nordisk's semaglutide and Eli Lilly's tirzepatide are set to become all-time best-selling drugs. Structure Therapeutics has entered the race with an oral GLP-1 ...

The products are being advertised as more affordable alternatives to blockbuster weight-loss drugs. Here’s what doctors think ...

Covering GLP-1 drugs under company health plans brings significant financial implications. These medications come with a ...

The current state of weight-loss treatments is about to shift with the forthcoming availability of GLP-1 drugs in the ...

Why fork over thousands of dollars a month for prescription weight loss jabs when store-bought supplements claim to have the ...

Half a century of advancements in biomedical science paved the way for today's powerful weight-loss drugs like Ozempic -- so ...

If you’ve found yourself unexpectedly humming the tune “Magic” lately, you’re not alone. Thanks to the catchy commercial for ...

In metabolic dysfunction-associated steatotic liver disease, a retrospective analysis shows that patients on GLP-1 receptor ...

The race is on to develop the first daily weight-loss pill that would be both cheaper and less invasive than the current ...

Explore how peptide drugs are changing the hundred-billion-level weight loss market, and how this landscape is changing as ...